Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2223-2025

Blood Agar,5% Sheep Blood 100/PK, Product Number R01202 Recall

Blood Agar,5% Sheep Blood 100/PK, Product Number R01202

FDA recall Class II

Ongoing

FDA lists this Class II recall for Blood Agar,5% Sheep Blood 100/PK, Product Number R01202. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2223-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jul 11, 2025
FDA report date
Aug 6, 2025
Quantity in commerce
1552 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Blood Agar,5% Sheep Blood 100/PK, Product Number R01202

Affected model & UDI checker

Search the exact identifiers published for Z-2223-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedBlood Agar,5% Sheep Blood 100/PK, Product Number R01202Check source notice848838000645
FDA code information

UDI-DI: 848838000645; Lot Numbers: 271595, 271596

View the original FDA recall notice

Why was this product recalled?

The products may contain surface and subsurface contamination of Listeria monocytogenes.

What actions did Remel, Inc take?

An Urgent: Medical Device Recall notification letter dated 7/11/25 was sent to customers. ACTIONS TO BE TAKEN BY THE CUSTOMER: Our records indicate that you have received above products. Accordingly, in keeping with our Quality Policy, we request that you please notify any personnel who need to be aware of the potential for visible contamination of products listed above and destroy any remaining inventory of lots listed above and complete the accompanying Acknowledgement form. Return the completed form indicating number of units destroyed via email to [email protected] in order for your replacement/credit to be processed. Complete and return the response form even if you no longer have the affected product on hand. Please keep this notification on file. This notice needs to be passed on to all who need to be aware within your organization or to any organization where the potentially affected products have been transferred. If you have any questions, please contact our Technical Services Department at 800-255-6730 (US) or email [email protected]. TYPE OF ACTION BY THE MANUFACTURER: Remel Inc., part of Thermo Fisher Scientific, is investigating the root cause and will implement corrective and preventive actions to prevent future recurrence.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology